Featured Insights

31. Key Takeaways From The ISPE Aseptic Processing Seminar 4/14/2025

    How is the pharmaceutical industry increasing aseptic processing safety? An ISPE event showcased innovations like robotics and improved risk management, aligning with recent regulatory guidance.

32. Essential Guide To Post-Approval Regulatory Lifecycle Maintenance 4/14/2025

    Learn about the growing trend of regulatory affairs outsourcing in pharma, driven by R&D growth and the need for specialized expertise to manage product lifecycles effectively.

33. The Advantages Of Pharmacovigilance Outsourcing At The Local Level 4/14/2025

    Outsourcing pharmacovigilance tasks can free up local teams for strategic work. Learn how to build effective partnerships by aligning needs, understanding capabilities, and fostering collaboration.

34. Key Takeaways From PDA Ireland Microbiology Event On Innovation And Technology 4/14/2025

    Insights from a PDA Ireland event reveal how innovative technologies like VR and automation are transforming sterile manufacturing, improving efficiency and addressing contamination control strategies.

35. How Healthy Is Your TMF? A Check-In Before An Inspection 3/18/2025

    Explore how proper oversight of the Trial Master File (TMF) prevents inspection findings. Regular reviews, heatmaps, and risk-based assessments help ensure TMF health, and readiness for regulatory inspections.

36. Five Key Trends In CMC 3/18/2025

    CMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.

37. Three Key Takeaways: Best Practices In Environmental Monitoring 3/18/2025

    An Environmental Monitoring (EM) program ensures microbial and particulate control in sterile manufacturing. A conference in India covered EM design, data interpretation, contamination risks, and regulatory expectations.

38. Effective Digital Engagement For Biopharma Companies 3/18/2025

    The NASP Podcast explores biopharma digital engagement, emphasizing strategic communication, data analytics, and best practices to enhance healthcare decision-maker engagement across a product’s lifecycle.

39. Rising Sun: The Drug Pricing Environment In Japan Is On The Up 3/18/2025

    Japan’s recent pharmaceutical pricing reforms present new opportunities for the industry, fostering innovation while aiming to ensure faster access to treatments.

40. Early Network Mapping To Guide HTA Literature Reviews 3/18/2025

    How do we identify the right evidence efficiently? Early network mapping can help manufacturers balance a focused scope with the need to conduct indirect treatment comparisons.